nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.398	0.441	CbGbCtD
Triflupromazine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.367	0.407	CbGbCtD
Triflupromazine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0708	0.0785	CbGbCtD
Triflupromazine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0669	0.0741	CbGbCtD
Triflupromazine—BCHE—diaphragm—chronic obstructive pulmonary disease	0.0132	0.461	CbGeAlD
Triflupromazine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.00166	0.0581	CbGeAlD
Triflupromazine—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00166	0.0578	CbGeAlD
Triflupromazine—CHRM1—trachea—chronic obstructive pulmonary disease	0.00153	0.0533	CbGeAlD
Triflupromazine—BCHE—respiratory system—chronic obstructive pulmonary disease	0.00151	0.0527	CbGeAlD
Triflupromazine—Cinacalcet—CYP1A2—chronic obstructive pulmonary disease	0.00124	0.0729	CrCbGaD
Triflupromazine—BCHE—bronchus—chronic obstructive pulmonary disease	0.00124	0.0433	CbGeAlD
Triflupromazine—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.00122	0.0424	CbGeAlD
Triflupromazine—BCHE—trachea—chronic obstructive pulmonary disease	0.00112	0.0389	CbGeAlD
Triflupromazine—CHRM1—lung—chronic obstructive pulmonary disease	0.0011	0.0383	CbGeAlD
Triflupromazine—HTR2B—lung—chronic obstructive pulmonary disease	0.00109	0.0381	CbGeAlD
Triflupromazine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000934	0.0548	CrCbGaD
Triflupromazine—DRD2—lung—chronic obstructive pulmonary disease	0.000884	0.0308	CbGeAlD
Triflupromazine—BCHE—lung—chronic obstructive pulmonary disease	0.000801	0.028	CbGeAlD
Triflupromazine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.000787	0.0462	CrCbGaD
Triflupromazine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000719	0.0251	CbGeAlD
Triflupromazine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000576	0.0338	CrCbGaD
Triflupromazine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000532	0.0185	CbGeAlD
Triflupromazine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.000506	0.0297	CrCbGaD
Triflupromazine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.0005	0.0294	CrCbGaD
Triflupromazine—Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000498	0.0293	CrCbGaD
Triflupromazine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.000494	0.029	CrCbGaD
Triflupromazine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.000486	0.0286	CrCbGaD
Triflupromazine—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.00048	0.0282	CrCbGaD
Triflupromazine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000456	0.0268	CrCbGaD
Triflupromazine—Desipramine—ADRB2—chronic obstructive pulmonary disease	0.000443	0.026	CrCbGaD
Triflupromazine—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.000429	0.0252	CrCbGaD
Triflupromazine—Fluphenazine—HTR2A—chronic obstructive pulmonary disease	0.00042	0.0247	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	0.00041	0.0241	CrCbGaD
Triflupromazine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	0.000404	0.0237	CrCbGaD
Triflupromazine—Desipramine—SLC6A4—chronic obstructive pulmonary disease	0.000403	0.0236	CrCbGaD
Triflupromazine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.000398	0.0234	CrCbGaD
Triflupromazine—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000394	0.0231	CrCbGaD
Triflupromazine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	0.000385	0.0226	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.000383	0.0225	CrCbGaD
Triflupromazine—ABCB1—lung—chronic obstructive pulmonary disease	0.000382	0.0133	CbGeAlD
Triflupromazine—Desipramine—CYP1A2—chronic obstructive pulmonary disease	0.000367	0.0215	CrCbGaD
Triflupromazine—Thioridazine—HTR2A—chronic obstructive pulmonary disease	0.000362	0.0213	CrCbGaD
Triflupromazine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000355	0.0209	CrCbGaD
Triflupromazine—Acepromazine—ALB—chronic obstructive pulmonary disease	0.000346	0.0203	CrCbGaD
Triflupromazine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	0.000346	0.0203	CrCbGaD
Triflupromazine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	0.000341	0.02	CrCbGaD
Triflupromazine—Promethazine—HTR2A—chronic obstructive pulmonary disease	0.000341	0.02	CrCbGaD
Triflupromazine—Thioproperazine—ALB—chronic obstructive pulmonary disease	0.000338	0.0199	CrCbGaD
Triflupromazine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	0.000336	0.0197	CrCbGaD
Triflupromazine—Pipotiazine—ALB—chronic obstructive pulmonary disease	0.000333	0.0195	CrCbGaD
Triflupromazine—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000332	0.0195	CrCbGaD
Triflupromazine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	0.000312	0.0184	CrCbGaD
Triflupromazine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.0183	CrCbGaD
Triflupromazine—Desipramine—HTR2A—chronic obstructive pulmonary disease	0.000309	0.0182	CrCbGaD
Triflupromazine—Promazine—HTR2A—chronic obstructive pulmonary disease	0.0003	0.0176	CrCbGaD
Triflupromazine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	0.000264	0.0155	CrCbGaD
Triflupromazine—Clomipramine—ALB—chronic obstructive pulmonary disease	0.000263	0.0155	CrCbGaD
Triflupromazine—Imipramine—HTR2A—chronic obstructive pulmonary disease	0.000262	0.0154	CrCbGaD
Triflupromazine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	0.00018	0.0106	CrCbGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.75e-05	0.00189	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.75e-05	0.00189	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.62e-05	0.00186	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	9.62e-05	0.00186	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.49e-05	0.00184	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.43e-05	0.00183	CbGpPWpGaD
Triflupromazine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	9.4e-05	0.00182	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.32e-05	0.00181	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.28e-05	0.0018	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.21e-05	0.00179	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.2e-05	0.00178	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.16e-05	0.00178	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.08e-05	0.00176	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	9.06e-05	0.00176	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.89e-05	0.00172	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	8.87e-05	0.00172	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	8.86e-05	0.00172	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.79e-05	0.0017	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.71e-05	0.00169	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.71e-05	0.00169	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.61e-05	0.00167	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.53e-05	0.00165	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.49e-05	0.00164	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.43e-05	0.00163	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.42e-05	0.00163	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.32e-05	0.00161	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.31e-05	0.00161	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.2e-05	0.00159	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	8.14e-05	0.00158	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	7.96e-05	0.00154	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.65e-05	0.00148	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.58e-05	0.00147	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.56e-05	0.00147	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	7.5e-05	0.00145	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.48e-05	0.00145	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	7.47e-05	0.00145	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	7.46e-05	0.00145	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.42e-05	0.00144	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.39e-05	0.00143	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.37e-05	0.00143	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.34e-05	0.00142	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.33e-05	0.00142	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.15e-05	0.00138	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.13e-05	0.00138	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.98e-05	0.00135	CbGpPWpGaD
Triflupromazine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	6.97e-05	0.00135	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.94e-05	0.00135	CbGpPWpGaD
Triflupromazine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	6.88e-05	0.00133	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.8e-05	0.00132	CbGpPWpGaD
Triflupromazine—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	6.77e-05	0.00131	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.74e-05	0.00131	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.74e-05	0.00131	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.71e-05	0.0013	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.71e-05	0.0013	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.64e-05	0.00129	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.57e-05	0.00127	CbGpPWpGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	6.54e-05	0.00127	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.49e-05	0.00126	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.49e-05	0.00126	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.41e-05	0.00124	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.35e-05	0.00123	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.32e-05	0.00122	CbGpPWpGaD
Triflupromazine—DRD1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	6.24e-05	0.00121	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.12e-05	0.00119	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.02e-05	0.00117	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.77e-05	0.00112	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.76e-05	0.00112	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.76e-05	0.00112	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	5.74e-05	0.00111	CbGpPWpGaD
Triflupromazine—DRD1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	5.71e-05	0.00111	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	5.69e-05	0.0011	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.68e-05	0.0011	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	5.51e-05	0.00107	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.47e-05	0.00106	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.43e-05	0.00105	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.43e-05	0.00105	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.41e-05	0.00105	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.38e-05	0.00104	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	5.35e-05	0.00104	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.27e-05	0.00102	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.27e-05	0.00102	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.2e-05	0.00101	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.2e-05	0.00101	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.16e-05	0.000999	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.1e-05	0.000988	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.09e-05	0.000986	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.99e-05	0.000967	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.98e-05	0.000965	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.97e-05	0.000963	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.97e-05	0.000962	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.92e-05	0.000953	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	4.88e-05	0.000946	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.84e-05	0.000937	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.8e-05	0.00093	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.78e-05	0.000927	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	4.71e-05	0.000912	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.69e-05	0.00091	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.63e-05	0.000898	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	4.61e-05	0.000893	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.51e-05	0.000874	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.5e-05	0.000872	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.5e-05	0.000871	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.36e-05	0.000844	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	4.31e-05	0.000835	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.29e-05	0.000831	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.26e-05	0.000826	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	4.22e-05	0.000817	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.21e-05	0.000816	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.21e-05	0.000815	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.2e-05	0.000813	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.14e-05	0.000802	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.1e-05	0.000795	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.1e-05	0.000794	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.02e-05	0.000779	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.01e-05	0.000778	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.01e-05	0.000777	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4e-05	0.000774	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.97e-05	0.00077	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.96e-05	0.000768	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.96e-05	0.000767	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.92e-05	0.000759	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.89e-05	0.000754	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.86e-05	0.000747	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.81e-05	0.000738	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.76e-05	0.000729	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.75e-05	0.000727	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.75e-05	0.000727	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.7e-05	0.000717	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.69e-05	0.000716	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.69e-05	0.000715	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.67e-05	0.000711	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	3.66e-05	0.000709	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.62e-05	0.000702	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.62e-05	0.000701	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.61e-05	0.0007	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.45e-05	0.000668	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.44e-05	0.000667	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.41e-05	0.00066	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.41e-05	0.00066	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.33e-05	0.000646	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.29e-05	0.000637	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.27e-05	0.000634	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.25e-05	0.000631	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.23e-05	0.000626	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.07e-05	0.000595	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.05e-05	0.00059	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.04e-05	0.000588	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3e-05	0.000581	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.95e-05	0.000573	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.94e-05	0.000569	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.94e-05	0.000569	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.9e-05	0.000561	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.83e-05	0.000547	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.79e-05	0.00054	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.79e-05	0.00054	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.77e-05	0.000536	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.73e-05	0.000529	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.69e-05	0.000522	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.66e-05	0.000516	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.64e-05	0.000512	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.63e-05	0.000509	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.61e-05	0.000506	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.57e-05	0.000499	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.52e-05	0.000488	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.49e-05	0.000482	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.48e-05	0.00048	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.38e-05	0.000462	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.32e-05	0.000449	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.31e-05	0.000449	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.3e-05	0.000446	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.27e-05	0.000439	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.25e-05	0.000436	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.24e-05	0.000434	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000431	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.22e-05	0.00043	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.2e-05	0.000425	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.16e-05	0.000418	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	2.13e-05	0.000412	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000408	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.09e-05	0.000405	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.06e-05	0.000399	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.06e-05	0.000399	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.05e-05	0.000396	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.04e-05	0.000395	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.03e-05	0.000394	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.02e-05	0.000391	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.01e-05	0.00039	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.97e-05	0.000381	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.97e-05	0.000381	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.94e-05	0.000377	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.94e-05	0.000377	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.87e-05	0.000362	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.86e-05	0.00036	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.83e-05	0.000355	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.83e-05	0.000355	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.81e-05	0.00035	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.81e-05	0.00035	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.75e-05	0.000338	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.68e-05	0.000326	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.66e-05	0.000322	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.65e-05	0.000319	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000309	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.58e-05	0.000306	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.57e-05	0.000303	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.54e-05	0.000298	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.5e-05	0.000292	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.49e-05	0.000289	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.49e-05	0.000288	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.47e-05	0.000284	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.44e-05	0.000278	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.42e-05	0.000275	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.42e-05	0.000275	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000271	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.37e-05	0.000266	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.35e-05	0.000262	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.34e-05	0.000259	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.3e-05	0.000252	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.28e-05	0.000247	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000241	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.23e-05	0.000238	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000236	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000233	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.2e-05	0.000233	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.18e-05	0.000229	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.16e-05	0.000224	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.14e-05	0.000221	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.12e-05	0.000218	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.1e-05	0.000213	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.09e-05	0.00021	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.08e-05	0.00021	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.07e-05	0.000208	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000201	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.01e-05	0.000196	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	0.000196	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.88e-06	0.000191	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.8e-06	0.00019	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.75e-06	0.000189	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.26e-06	0.00018	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.25e-06	0.000179	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.08e-06	0.000176	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.07e-06	0.000176	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.95e-06	0.000173	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.89e-06	0.000172	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.78e-06	0.00017	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.63e-06	0.000148	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.46e-06	0.000145	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.37e-06	0.000143	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.98e-06	0.000135	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.83e-06	0.000132	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.74e-06	0.000131	CbGpPWpGaD
